Phibro Animal Health Stock Analysis
PAHC Stock | USD 23.59 0.02 0.08% |
Phibro Animal Health is overvalued with Real Value of 19.84 and Target Price of 16.75. The main objective of Phibro Animal stock analysis is to determine its intrinsic value, which is an estimate of what Phibro Animal Health is worth, separate from its market price. There are two main types of Phibro Animal's stock analysis: fundamental analysis and technical analysis.
The Phibro Animal stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Phibro Animal's ongoing operational relationships across important fundamental and technical indicators.
Phibro |
Phibro Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The book value of Phibro Animal was at this time reported as 6.38. The company has Price/Earnings To Growth (PEG) ratio of 1.66. Phibro Animal Health last dividend was issued on the 27th of November 2024. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Anl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1860 people. To find out more about Phibro Animal Health contact Jack Bendheim at 201 329 7300 or learn more at https://www.pahc.com.Phibro Animal Quarterly Total Revenue |
|
Phibro Animal Health Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Phibro Animal's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Phibro Animal Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 99.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 32.31 subject to Rule 16b-3 |
Phibro Animal Health Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Phibro Animal previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of February 2024 Upcoming Quarterly Report | View | |
1st of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of September 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
30th of June 2023 Last Financial Announcement | View |
Phibro Largest EPS Surprises
Earnings surprises can significantly impact Phibro Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-02-08 | 2022-12-31 | 0.3 | 0.34 | 0.04 | 13 | ||
2022-02-09 | 2021-12-31 | 0.33 | 0.37 | 0.04 | 12 | ||
2021-11-02 | 2021-09-30 | 0.29 | 0.25 | -0.04 | 13 |
Phibro Animal Environmental, Social, and Governance (ESG) Scores
Phibro Animal's ESG score is a quantitative measure that evaluates Phibro Animal's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Phibro Animal's operations that may have significant financial implications and affect Phibro Animal's stock price as well as guide investors towards more socially responsible investments.
Phibro Stock Institutional Investors
Shares | Castleknight Management Lp | 2024-09-30 | 366.6 K | Nuveen Asset Management, Llc | 2024-06-30 | 346.6 K | Amvescap Plc. | 2024-06-30 | 289.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 268.4 K | Bank Of New York Mellon Corp | 2024-06-30 | 246.8 K | Sofinnova Ventures | 2024-06-30 | 237 K | Northern Trust Corp | 2024-09-30 | 228.7 K | Goldman Sachs Group Inc | 2024-06-30 | 226.9 K | Globeflex Capital, L.p. | 2024-09-30 | 204.9 K | Blackrock Inc | 2024-06-30 | 3.5 M | Vanguard Group Inc | 2024-09-30 | 1.5 M |
Phibro Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 955.48 M.Phibro Profitablity
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.Last Reported | Projected for Next Year | ||
Return On Capital Employed | 0.07 | 0.07 | |
Return On Equity | 0.01 | 0.01 |
Management Efficiency
Phibro Animal Health has return on total asset (ROA) of 0.0526 % which means that it generated a profit of $0.0526 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0655 %, meaning that it created $0.0655 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to 0. In addition to that, Return On Capital Employed is expected to decline to 0.07. At present, Phibro Animal's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.66, whereas Total Assets are forecasted to decline to about 568.4 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 6.34 | 6.65 | |
Tangible Book Value Per Share | 3.88 | 4.07 | |
Enterprise Value Over EBITDA | 16.58 | 17.41 | |
Price Book Value Ratio | 2.69 | 3.21 | |
Enterprise Value Multiple | 16.58 | 17.41 | |
Price Fair Value | 2.69 | 3.21 |
Examining the leadership quality of Phibro Animal Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield 0.0203 | Operating Margin 0.0811 | Profit Margin 0.0166 | Forward Dividend Yield 0.0203 | Beta 0.51 |
Technical Drivers
As of the 29th of November, Phibro Animal holds the Semi Deviation of 1.72, coefficient of variation of 1075.73, and Risk Adjusted Performance of 0.0779. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phibro Animal, as well as the relationship between them.Phibro Animal Health Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Phibro Animal middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Phibro Animal Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Phibro Animal Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phibro Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Corcoran E Thomas over two months ago Acquisition by Corcoran E Thomas of 5000 shares of Phibro Animal at 20.02 subject to Rule 16b-3 | ||
Daniel Bendheim over six months ago Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 11.83 subject to Rule 16b-3 | ||
Larry Miller over a year ago Acquisition by Larry Miller of 300000 shares of Phibro Animal subject to Rule 16b-3 |
Phibro Animal Outstanding Bonds
Phibro Animal issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Phibro Animal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Phibro bonds can be classified according to their maturity, which is the date when Phibro Animal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Phibro Animal Predictive Daily Indicators
Phibro Animal intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Phibro Animal stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Phibro Animal Corporate Filings
F3 | 15th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 5th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
16th of October 2024 Other Reports | ViewVerify |
Phibro Animal Forecast Models
Phibro Animal's time-series forecasting models are one of many Phibro Animal's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Phibro Animal's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Phibro Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Phibro Animal prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Phibro shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Phibro Animal. By using and applying Phibro Stock analysis, traders can create a robust methodology for identifying Phibro entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.01 | 0.01 | |
Operating Profit Margin | 0.05 | 0.06 | |
Gross Profit Margin | 0.31 | 0.22 |
Current Phibro Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Phibro analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Phibro analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
16.75 | Hold | 5 | Odds |
Most Phibro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Phibro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Phibro Animal Health, talking to its executives and customers, or listening to Phibro conference calls.
Phibro Stock Analysis Indicators
Phibro Animal Health stock analysis indicators help investors evaluate how Phibro Animal stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Phibro Animal shares will generate the highest return on investment. By understating and applying Phibro Animal stock analysis, traders can identify Phibro Animal position entry and exit signals to maximize returns.
Begin Period Cash Flow | 41.3 M | |
Long Term Debt | 458.3 M | |
Common Stock Shares Outstanding | 40.5 M | |
Total Stockholder Equity | 256.6 M | |
Tax Provision | 8.5 M | |
Quarterly Earnings Growth Y O Y | -0.935 | |
Property Plant And Equipment Net | 240.9 M | |
Cash And Short Term Investments | 114.6 M | |
Cash | 70.6 M | |
Accounts Payable | 85.6 M | |
Net Debt | 454.8 M | |
50 Day M A | 23.2726 | |
Total Current Liabilities | 204.1 M | |
Other Operating Expenses | 964.4 M | |
Non Current Assets Total | 381.2 M | |
Forward Price Earnings | 10.5708 | |
Non Currrent Assets Other | 9.8 M | |
Stock Based Compensation | 475 K |
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |